Friday, May 1, 2026

From Missiles to Marine Farms: Kim’s New Focus on Feeding the Nation

Kim Jong Un inspects a seaside aquaculture facility in North Korea, praising progress and emphasizing efficient development for coastal areas.

Beyond Defense: U.S. Expert Warns North Korea May Use Nukes First

U.S. experts warn of North Korea's evolving nuclear strategy, urging South Korea to adapt its defense policies to new threats.

Hanwha Lands $274 Million Deal to Power Poland’s KRAB Howitzers

Hanwha Aerospace secures a $274M contract with Poland's HSW for howitzer components, enhancing defense ties amid European rearmament efforts.

Tag: Neok Bio

ABL Bio to Invest Additional $25 Million in Neok Bio to Accelerate ADC Clinical Trials

ABL Bio invests $25M in Neok Bio for bispecific antibody-drug conjugate trials, aiming for FDA-approved treatments by 2027.

Unlocking Cancer Treatment: ABL206 and ABL209’s Promising Non-Clinical Data Revealed at AACR

ABL Bio will present preclinical data for its ADCs ABL206 and ABL209 at AACR 2023, showcasing promising anti-cancer efficacy.

ABL206: First-in-Class Dual Antibody Drug Conjugate Approved for Clinical Trials in the U.S. – What This Means for Cancer Treatment

ABL Bio and Neok Bio received FDA approval for ABL206, a dual-antibody ADC, marking a key milestone in their clinical development efforts.

Top News

- Our Sponsors Ad -

Follow us